Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IPERIONX LtdIPX · Entity 5162 | Director · Executive Chairman | July 10, 2026 | July 13, 2026 |
| Piedmont Lithium Inc.PLL · Entity 75957 | Director | February 27, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IPERIONX Ltd
Report date July 10, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| IPX Ordinary SharesSEC Table I · non-derivative | Direct | 26,633,334 |
Last balance in matching sequence
After 2026-07-13 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-10 · Purchase · Acquired 225,000 · Balance 26,333,334 F1: IperionX (IPX) Ordinary Shares are traded on the Australian Stock Exchange. F2: Australian dollars F3: average purchase price Row 2 · 2026-07-13 · Purchase · Acquired 300,000 · Balance 26,633,334 F1: IperionX (IPX) Ordinary Shares are traded on the Australian Stock Exchange. F2: Australian dollars F3: average purchase price |
| Restricted Stock Units (RSUs)SEC Table I · non-derivative | Direct | 454,464 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 454,464 F4: 159,334 vest in December 2026; 295,130 vest in April 2028 |
| Performance Rights (A$6)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2030-04-10 | Direct | 306,302 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 306,302 F2: Australian dollars |
| Performance Rights (A$7)SEC Table II · derivative / convertible security · Conversion / exercise price $7.00 · Expires 2030-04-10 | Direct | 306,302 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 306,302 F2: Australian dollars |
| Performance Rights (A$8)SEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2030-04-10 | Direct | 306,302 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 306,302 F2: Australian dollars |
| Performance Rights (A$18)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-04-02 | Direct | 196,086 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 196,086 F2: Australian dollars |
| Options (A$18)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-04-02 | Direct | 465,410 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 465,410 F2: Australian dollars |
| Options (A$22)SEC Table II · derivative / convertible security · Conversion / exercise price $22.00 · Expires 2031-04-02 | Direct | 526,760 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 526,760 F2: Australian dollars |
| American Depository Shares(ADS)SEC Table II · derivative / convertible security | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 50,000 F5: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is convertible into 10 Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). |
Filing footnotes · ownership attribution and instrument terms
F1: IperionX (IPX) Ordinary Shares are traded on the Australian Stock Exchange.
F2: Australian dollars
F3: average purchase price
F4: 159,334 vest in December 2026; 295,130 vest in April 2028
F5: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is convertible into 10 Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange).
Piedmont Lithium Inc.
Report date February 27, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 2,646 |
Reported balance
After 2022-02-27 transaction · row 1
1 source rowRow 1 · 2022-02-27 · Grant · Acquired 1,449 · Balance 2,646 F1: The grant of the RSUs is subject to shareholder approval, and the RSUs will vest immediately upon shareholder approval. Such RSUs will be restricted from sale so long as the reporting person is a director of the Company. |
| Common Stock, par value $0.0001SEC Table I · non-derivative | IndirectDITM Holdings Pty Ltd | 356,279 |
Reported balance
Holding disclosure · report date 2022-02-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 356,279 |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of the RSUs is subject to shareholder approval, and the RSUs will vest immediately upon shareholder approval. Such RSUs will be restricted from sale so long as the reporting person is a director of the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2026 Filed Jul 13, 2026 12:16 UTC | IPERIONX Ltd IPX · Entity 5162 | PurchaseIPX Ordinary Shares | 300,000 | $3.59 | $1,075,980.00 |
DisclosureSEC source: 0001864148-26-000007 · primary_doc.xml · nonDerivative · entry 2 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,633,334 F1 · security: IperionX (IPX) Ordinary Shares are traded on the Australian Stock Exchange. F2 · price: Australian dollars F3 · price: average purchase price Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 12:16 UTC | IPERIONX Ltd IPX · Entity 5162 | PurchaseIPX Ordinary Shares | 225,000 | $3.58 | $805,185.00 |
DisclosureSEC source: 0001864148-26-000007 · primary_doc.xml · nonDerivative · entry 1 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,333,334 F1 · security: IperionX (IPX) Ordinary Shares are traded on the Australian Stock Exchange. F2 · price: Australian dollars F3 · price: average purchase price Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 01:51 UTC | IPERIONX Ltd IPX · Entity 5162 | PurchaseOrdinary Shares | 260,000 | $4.20 | $1,091,766.00 |
DisclosureSEC source: 0001864148-26-000006 · primary_doc.xml · nonDerivative · entry 2 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,108,334 F4 · security: American Depository Shares (ADS) are traded on the NASDAQ. One ADS is convertible into 10 ordinary shares (ordinary shares are traded on the Australian Stock Exchange). Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 01:51 UTC | IPERIONX Ltd IPX · Entity 5162 | PurchaseOrdinary Shares | 220,000 | $4.48 | $986,018.00 |
DisclosureSEC source: 0001864148-26-000006 · primary_doc.xml · nonDerivative · entry 1 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,848,334 F1 · security: Ordinary Shares are traded on the Australian Stock Exchange F2 · price: Australian dollars F3 · price: average purchase price Read SEC document |
| April 02, 2026 Filed Apr 2, 2026 23:09 UTC | IPERIONX Ltd IPX · Entity 5162 | GrantOptions (A$22) · Derivative | 526,760 | Not disclosed Strike: $22.00 | Not disclosed |
DisclosureSEC source: 0001864148-26-000005 · primary_doc.xml · derivative · entry 9 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,760 Underlying: IPX Ordinary Shares · 526,760 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars F7 · price: Each option confers the right to purchase one ordinary share at the conversion price. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document |
| April 02, 2026 Filed Apr 2, 2026 23:09 UTC | IPERIONX Ltd IPX · Entity 5162 | GrantOptions (A$18) · Derivative | 465,410 | Not disclosed Strike: $18.00 | Not disclosed |
DisclosureSEC source: 0001864148-26-000005 · primary_doc.xml · derivative · entry 8 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,410 Underlying: IPX Ordinary Shares · 465,410 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars F7 · price: Each option confers the right to purchase one ordinary share at the conversion price. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document |
| April 02, 2026 Filed Apr 2, 2026 23:09 UTC | IPERIONX Ltd IPX · Entity 5162 | GrantPerformance Rights (A$18) · Derivative | 196,086 | Not disclosed Strike: $18.00 | Not disclosed |
DisclosureSEC source: 0001864148-26-000005 · primary_doc.xml · derivative · entry 7 Hannigan Todd · CIK 0001864148 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,086 Underlying: IPX Ordinary Shares · 196,086 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars F6 · price: Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 12:57 UTC | IPERIONX Ltd IPX · Entity 5162 | PurchaseOrdinary Shares | 225,225 | $3.20 | $720,922.70 |
DisclosureSEC source: 0001864148-26-000004 · primary_doc.xml · nonDerivative · entry 1 Hannigan Todd · CIK 0001864148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,628,334 F1 · security: Ordinary Shares are traded on the Australian Stock Exchange (ASX). F2 · price: This is the average purchase price. F3 · price: Australian dollars. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 15:30 UTC | Piedmont Lithium Inc. PLL · Entity 75957 | GrantCommon Stock, par value $0.0001 | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-007611 · form4.xml · nonDerivative · entry 1 Hannigan Todd · CIK 0001864148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,646 F1 · shares: The grant of the RSUs is subject to shareholder approval, and the RSUs will vest immediately upon shareholder approval. Such RSUs will be restricted from sale so long as the reporting person is a director of the Company. Read SEC document |
| February 03, 2022 Filed Feb 10, 2022 19:58 UTC | Piedmont Lithium Inc. PLL · Entity 75957 | GrantCommon Stock, par value $0.0001 | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004478 · form4.xml · nonDerivative · entry 1 Hannigan Todd · CIK 0001864148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 F1 · shares: Represents RSUs vesting in three equal annual installments beginning December 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.